MSF Scientific Days bring together researchers, practitioners, academics and patient representatives to catalyse improvements in the quality of care provided to patients and populations at risk.
Presentation
Session 4 – Evolving Thinking: Adapting Programming
Date: Wednesday, 13 May 2020
- Safety and efficacy data from a phase 2 randomized trial of a miltefosine/thermotherapy
combination in uncomplicated New World cutaneous leishmaniasis
Byron Arana, Head of Cutaneous Leishmaniasis, DNDi - Incidence of relapse at three months in young children who recovered under the OptiMA strategy for management of acute malnutrition: prospective cohort, Burkina Faso
Kevin Phelan, The Alliance for International Medical Action (ALIMA), Paris, France - Lived experiences and perceptions of palliative care among advanced HIV patients:
qualitative study, Bihar, India
Pragya Kumar, All India Institute of Medical Sciences, Patna, India - Extreme differentiated service delivery (DSD) models of HIV care during conflict: MSF experience in Zemio (CAR)
Charles Ssonko, MSF
More information: